Investing Profile

Cillian King

VCInvestor
Managing Director at EQT Life Sciences
eqtgroup.com/about/people/cil...Amsterdam, Netherlands
Photo of Cillian King, Managing Director at EQT Life Sciences
Your Intro Paths to Cillian King
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Networks Cillian is a member of
Massachusetts Institute of Technology (MIT) Network
12 CONNECTIONS

Find Cillian King on

cb
Current Investing Position
EQT Life Sciences Managing Director
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
1
Current Fund Size
€260M

Cillian King is on these Sector & Stage Rankings

Cillian King's Investments On Record (1)

CompanyStageDateRound SizeTotal Raised
QurAlis
Series BMar 2023$88M
$140M
Co-investors: Amy Schulman (Polaris Partners), Jeffrey Moore (MP Healthcare Venture Management), Johannes Fruehauf (Mission BioCapital), Philip Scheltens (EQT Life Sciences), Roel Bulthuis (INKEF Capital), Laia Crespo (Sanofi Ventures), Stephen Thompson (Brandon Capital Partners)

Cillian King's Experience

Board Member QurAlis2023 - Present
Managing Director EQT Group2022 - Present
Board Member Muna Therapeutics2021 - Present
Board Member Sairopa B.V.2021 - Present
Founder Koala Life Sciences2017 - Present
Investment Manager EQT Group2021 - 2022
Board Member Pan Cancer T2020 - 2021
Board Member Allero Therapeutics2019 - 2021
Investment Manager Swanbridge Capital2018 - 2021
Team leader | Life Sciences Catalyze - Carrying Ideas Forward2015 - 2017
Research Fellow Massachusetts Institute of Technology (MIT)2009 - 2009
Intern CNCR, Center for Neurogenomics & Cognitive Research2008 - 2008

Cillian King's Education

BioBusiness Summer School
Vrije Universiteit Amsterdam (VU Amsterdam) Doctor of Philosophy - PhD Molecular Neurosciences